Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Submission of Information about Selected Drugs and Their Therapeutic Alternatives for Medicare Drug Price Negotiation Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2026 · third_quarter · Q3
FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Source: Senate LDA
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare: comments on proposed HOPPS rule (CMS-1850-P) Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements: comments on Medicaid community engagement IFR (CMS-2454-IFC)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
To advance policy priorities that will break the gridlock.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Metastatic Breast Cancer Access to Care Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements
Metastatic Breast Cancer Access to Care Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Submission of Information about Selected Drugs and Their Therapeutic Alternatives for Medicare Drug Price Negotiation Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Metastatic Breast Cancer Access to Care Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Health Care Affordability Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Breast Cancer Research Stamp Reauthorization Act of 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Breast Cancer Stamp Reauthorization Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Implementation of the Affordable Care Act HELP Copays Act (S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Comments Re: Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act Comments RE: Proposed Rule on Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program Policies related to inclusion of new ICD-10 codes for inflammatory breast cancer and the coverage of External Breast Prostheses in Medicare
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
To advance policy priorities that will break the gridlock.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Metastatic Breast Cancer Access to Care Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Access to clinical trials for underrepresented populations Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments Comments RE: Re: Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule
Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, Comments in response to proposed updates to HRSA-Supported Womens Preventive Services Guidelines Policies to remove the notice and comment process for a wide array of agency actions Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Health Care Affordability Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Health Care Affordability Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Implementation of the Affordable Care Act HELP Copays Act (S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Comments Re: Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule outlining revisions to Medicare Advantage (MA) and Medicare Part D for Contract Year 2026. Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 842/S 339); a bill to provide for Medicare coverage of multi-cancer early detection screening tests.
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Implementation of the Affordable Care Act HELP Copays Act (S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Comments Re: Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P)
Access to Breast Cancer Diagnosis Act of 2025
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Access to clinical trials for underrepresented populations Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments Comments RE: Re: Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Client: SUSAN G. KOMEN · Firm: ARTEMIS POLICY GROUP LLC
Medicare coverage policy for breast cancer treatments and services Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule outlining revisions to Medicare Advantage (MA) and Medicare Part D for Contract Year 2026. Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 842/S 339); a bill to provide for Medicare coverage of multi-cancer early detection screening tests.
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · third_quarter · Q3
Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics: Letter to CDC Director Erica Schwartz re Division of Blood Disorders & Public Health Genomics
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Issues related to reimbursement for hemophilia services and treatments in Medicare: comments on proposed HOPPS rule (CMS-1850-P) Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements: comments on Medicaid community engagement IFR (CMS-2454-IFC)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2026 · second_quarter · Q2
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements
FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements
Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2026 · first_quarter · Q1
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
FY26 and FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 and FY27 appropriations for breast cancer research FY26 and FY27 appropriations for cancer prevention and control
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act Submission of Information about Selected Drugs and Their Therapeutic Alternatives for Medicare Drug Price Negotiation Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Comments RE: HHS Health Sector AI RFI Comments RE: Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N, (Annual Solicitation)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY26 Funding for federal hemophilia programs at CDC and HRSA for FY27
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2025 · fourth_quarter · Q4
FY26 appropriations for the National Breast and Cervical Cancer Early Detection Program FY26 appropriations for breast cancer research FY26 appropriations for cancer prevention and control
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions Letter to House Committee on Ways & Means Health Subcommittee in response to hearing on Modernizing Care Coordination to Prevent and Treat Chronic Disease
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · fourth_quarter · Q4
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2025 · third_quarter · Q3
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2025 · second_quarter · Q2
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Implementation of the Affordable Care Act HELP Copays Act (S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products One Big Beautiful Bill Act (H.R.1) including policies impacting the affordability and accessibility of insurance Comments Re: Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2025 · first_quarter · Q1
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging
Access to Breast Cancer Diagnosis (ABCD) Act; a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Safe Step Act; a bill to require a group health plan to establish an exception to medication step-therapy protocol in specified cases. Implementation of the Affordable Care Act HELP Copays Act (/S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to copay accumulator and maximizer adjustors Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 247 / S. 46) a bill to expand eligibility for the refundable credit for coverage under a qualified health plan. Protect patients from substandard and junk insurance products
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid PBM Reform amendments to Medicaid and Medicare in Continuing Resolution draft legislation
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2024 · fourth_quarter · Q4
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY25 House and Senate Labor-HHS Appropriations bills (H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025) Policies related to report language on the implementation of the Medicare Prescription Payment Plan. Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to ICD-10 code for inflammatory breast cancer Comments in response to FDA guidance, Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice (FDA-2024-D-2052) Comments in response to proposed updates to HRSA-Supported Womens Preventive Services Guidelines
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2024 · fourth_quarter · Q4
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Congressional sign-on letter to HHS/Treasury/Labor asking them to release promised rule closing the EHB loophole for ERISA plans Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P)
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2024 · third_quarter · Q3
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R.3086/S.5141 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Comments in response to CY 2025 Medicare Physician Fee Schedule Comments in response to CY 2025 Medicare HOPPS proposed rule
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2024 · third_quarter · Q3
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Comment letter in response to CY 2025 Medicare Physician Fee Schedule proposed rule
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) AIMED Alliance Citizens Petition re drug importation and alternative payment models
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2024 · second_quarter · Q2
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act (H.R. 4189/S. 2016) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Equitable Community Access to Pharmacist Services Act (S. 2477/H.R. 1770) Access to Genetic Counselor Services Act (H.R.3876/S.2323) Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P). Comments RE: Request for Information on Medicare Advantage Data
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2024 · second_quarter · Q2
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Letter to the Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2024 · first_quarter · Q1
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act, including comments on proposed rule re: Federal Independent Dispute Resolution Operations Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator adjustors Comments related to the Mental Health Parity and Addiction Equity Act Letter to Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2024 · first_quarter · 1T
Appropriations for the CDC
Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act Comments related to the Mental Health Parity and Addiction Equity Act
Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2024 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Hemophilia Gene Therapy coverage and payment policy request for meeting with CMS HR 3561 Section related to Medicaid transparency and drug pricing Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).
Funding for federal hemophilia programs
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Letter to the Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2024 · first_quarter · Q1
Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).
Appropriations for the CDC
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2023 · fourth_quarter · Q4
Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Comments on Processes for Assessing Compliance with Mental Health Parity and Addiction Equity in Medicaid and CHIP Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion
Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2023 · fourth_quarter · Q4
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator adjustors Comments related to the Mental Health Parity and Addiction Equity Act
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2023 · fourth_quarter · Q4
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid HR 3561 Section related to Medicaid transparency and drug pricing Hemophilia Gene Therapy coverage and payment policy request for meeting with CMS
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2023 · third_quarter · Q3
Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act
Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy
Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2023 · third_quarter · Q3
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA) (S. 2243) Comments in response to the discussion draft of the Stop Drug Shortages Act Letter to Congressional leadership related to drug shortages
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2023 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3561 Section related to Medicaid transparency and drug pricing Comments in response to Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2024
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2023 · second_quarter · Q2
Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers Provided input on Rare Disease Endpoint Advancement Pilot Program and Workshop
Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2023 · second_quarter · Q2
Clinical Trials Diversity Act Comments in response to Congressional RFI re CDC
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2023 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3561 Section related to Medicaid transparency and drug pricing Comments in response to Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2024
Funding for federal hemophilia programs
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2023 · first_quarter · Q1
Comments in response to proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges Comments in response to Request for Information on Essential Health Benefits Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Policies related to prior authorization, including step therapy
Policies related to health care and access to services for children and youth with special health care needs Activities related to being a Healthy People 2030 Champion Support for caregivers
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2023 · first_quarter · Q1
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges Comments in response to Request for Information on Essential Health Benefits Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses tissue from the lower abdomen to create a new breast
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2023 · first_quarter · Q1
Funding for federal hemophilia programs
Issues related to reimbursement for hemophilia services and treatments in Medicare Issuers related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act
Issues related to participation in the 340B Drug Discount Program Comments on Proposed Changes to the 340B Administrative Dispute Resolution (Docket No. HRSA-2021-000X)
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2023 · first_quarter · 1T
Reintroduction of Sickle Cell Disease Comprehensive Care Act Request for a Center for Medicare and Medicaid Innovation demonstration program for sickle cell disease, including the Sickle Cell Disease Comprehensive Care Act
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Reintroduction of The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases
Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · 4T
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research RFI on NIH-Wide Strategic Plan for Research on the Health of Women (Notice Number: NOT-OD-22-186) Advance Notice of Proposed Rulemaking: Trade Regulation Rule on Commercial Surveillance and Data Security (R111004)
Reproductive Health Services Interim Final Rule, RIN: 2900-AR57
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · Q4
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research RFI on NIH-Wide Strategic Plan for Research on the Health of Women (Notice Number: NOT-OD-22-186) Advance Notice of Proposed Rulemaking: Trade Regulation Rule on Commercial Surveillance and Data Security (R111004)
Issues related to mifepristone
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · Q4
Appropriations for access to telehealth services for children and youth with special health care needs Appropriation for Telehealth Resource Centers program at HRSA Policies related to paid family and medical leave Appropriations for federal epilepsy activities Appropriations for NIH and CDC
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Section 1557, Nondiscrimination in Health Programs and Activities (RIN Number 0945-AA17) Supporting the Reauthorization of the Orphan Drug Program Declaration of National Epilepsy Awareness Month
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · Q4
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067/ H.R. 5769) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (H.R. 7045/S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act (S. 942) HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to the RFI on Advanced Explanation of Benefits and Good Faith Estimate for Covered Individuals (CMS9900-NC) Implementation of the No Surprises Act
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · Q4
FDA policies related to research and approvals of treatments for hematological diseases
H.R. 2617 - Consolidated Appropriations Act of 2023 - NIH and funding of CDC sickle cell data collection program FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act H.R. 2617 - Consolidated Appropriations Act of 2023 - Medicare provisions to eliminate cuts in physician payment and Medicaid provisions related to inclusion of S.3389/HR 6216. Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Request for a Center for Medicare and Medicaid Innovation demonstration program for sickle cell disease
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2022 · fourth_quarter · Q4
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
Issues related to participation in the 340B Drug Discount Program
Funding for federal hemophilia programs
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2022 · third_quarter · Q3
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to paid family and medical leave Policies related to development of the Advanced Research Projects Agency for Health Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc Addition in any reconciliation package of policies related to health insurance coverage and affordability, including permanent extension of Advanced Premium Tax Credits provided by the American Rescue Plan, closing the Medicaid coverage gap, and a cap on out-of-pocket costs for Medicare Part D beneficiaries
Breast cancer research at the Department of Defense H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2022 · third_quarter · Q3
FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
FDA policies related to research and approvals of treatments for hematological diseases
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2023 Rates Comments in response to CY2023 Medicare Physician Fee Schedule (CMS-1770-P) National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2022 · third_quarter · Q3
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Input on federal policies that contribute to racial and ethnic health inequities, as well as potential solutions that could improve health equity Request for Applications for New Members of the Clinical Trials Transformation Initiative/Food and Drug Administration Patient Engagement Collaborative [Docket No. FDA-2017-N-6395]
Appropriations for access to telehealth services for children and youth with special health care needs Appropriation for Telehealth Resource Centers program at HRSA Policies related to paid family and medical leave
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via ARTEMIS POLICY GROUP LLC
2022 · third_quarter · Q3
Issues related to mifepristone
Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum Graduate medical education
Reproductive Health Services Interim Final Rule, RIN: 2900-AR57
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2022 · third_quarter · Q3
Issues related to participation in the 340B Drug Discount Program
Funding for federal hemophilia programs
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Comments on future rulemaking for the 2024 Notice on Benefit and Payment Parameters The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · 2A
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research
Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · RR
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · Q2
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Comments on the Affordability of Employer Coverage for Family Members of Employees Submission of telehealth and whole genome sequencing as topics for evidence review NOT-TR-21-027 - Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
Policies related to development of the Advanced Research Projects Agency for Health
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · Q2
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act (S. 942) HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies regarding White House Cancer Moonshot implementation Issues related to regulation of short-term limited duration plans Comments on the Affordability of Employer Coverage for Family Members of Employees
Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services and the Equitable Community Access to Pharmacist Services Act (H.R.7213) Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024 Medicare coverage policy for drugs and drug pricing Comments in response to CMS Request for Information on Access to Coverage and Care in Medicaid and Chip
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · Q2
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Issues related to Sickle Cell Disease Treatment Centers 2021 Sickle Cell Disease Awareness Month Resolution The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Implementation of No Surprises Act Affordability of Employer Coverage for Family Members of Employees (REG-114339-21)
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2022 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act CMS-1765-P; Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2022 · first_quarter · Q1
Policies related to development of the Advanced Research Projects Agency for Health
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Response to Requests for Information from the Healthy Futures Task Force Response to White House RFI on Strengthening Community Health Through Technology
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2022 · first_quarter · Q1
Breast cancer research at the Department of Defense H.R. 4350/S. 1605 - National Defense Authorization Act for Fiscal Year 2022; a bill to authorize Department of Defense activities and programs for FY 2022
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to paid family and medical leave Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289) Build Back Better Act (HR 5376) Policies related to development of the Advanced Research Projects Agency for Health Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2022 · first_quarter · Q1
FDA policies related to research and approvals of treatments for hematological diseases
FY 2022 and FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) The Sickle Cell Care Expansion Act (H.R. 7177)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2022 · first_quarter · Q1
Funding for federal hemophilia programs
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
Issues related to participation in the 340B Drug Discount Program
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2021 · fourth_quarter · Q4
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers
Policies related to development of the Advanced Research Projects Agency for Health
Appropriations for access to telehealth services for children and youth with special health care needs Build Back Better Act (HR 5376) Policies related to paid family and medical leave
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2021 · fourth_quarter · Q4
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Policies related to paid family and medical leave Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289) Build Back Better Act (HR 5376)
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(S.2412) Safe Step Act (H.R. 2163/S. 464) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2021 · fourth_quarter · Q4
FDA policies related to research and approvals of treatments for hematological diseases
FY 2022 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait 2021 Sickle Cell Disease Awareness Month Resolution Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Responding to Social Determinants of Health Caucus Request for Information Implementation of No Surprises Act
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2021 · fourth_quarter · Q4
Funding for federal hemophilia programs
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model The HELP Copays Act (HR 5801) The Protect 340B Act (HR 4390)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2021 · third_quarter · Q3
Appropriations for access to telehealth services for children and youth with special health care needs Build Back Better Act (HR 5376) Policies related to paid family and medical leave
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs CONNECT for Health Act (S.1512/ H.R. 2903) Request to become Health People 2030 Champion Cures 2.0 Legislation
Policies related to development of the Advanced Research Projects Agency for Health
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2021 · third_quarter · Q3
Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (HR 3517/S 1943) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion
Breast cancer research at the Department of Defense
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2021 · third_quarter · Q3
FDA policies related to research and approvals of treatments for hematological diseases
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait 2021 Sickle Cell Disease Awareness Month Resolution Healthcare issues related to hematologic diseases CURES 2.0 draft legislation Responding to Social Determinants of Health Caucus Request for Information
FY 2022 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2021 · third_quarter · Q3
Issues related to participation in the 340B Drug Discount Program
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3, Elijah E. Cummings Lower Drug Costs Now Act
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Accumulator adjustor issues Protect 340B Act (HR 4390) HHS Request for Information Regarding Reporting on Pharmacy Benefits and Prescription Drug Costs
THE SOCIETY FOR MATERNAL-FETAL MEDICINE via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · 2T
Appropriations for research related to use of therapeutics in pregnant and lactating people
Policies related to COVID-19 vaccinations and pregnant and lactating people Policies related to implementation of recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
THE SOCIETY FOR MATERNAL-FETAL MEDICINE via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · Q2
Appropriations for research related to use of therapeutics in pregnant and lactating people
Policies related to COVID-19 vaccinations and pregnant and lactating people Policies related to implementation of recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · Q2
Appropriations for access to telehealth services for children and youth with special health care needs
NINDS: Strategic Plan for Research 2021-2026 NCATS RFI on Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs OMB RFI on Methods and Leading Practices for Advancing Equity and Support for Underserved Communities through Government CONNECT for Health Act (S.1512/ H.R. 2903)
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · Q2
Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (HR 3517/S 1943) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act Safe Step Act (H.R. 2163/S. 464) Protecting Americans with Pre-Existing Conditions Act of 2021 (S. 779) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act Accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · Q2
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Healthcare issues related to hematologic diseases CURES 2.0 draft legislation
Sickle Cell Disease Medicaid Demonstration Program draft legislation Making permanent Medicare telehealth expansions allowed during Public Health Emergency Coverage of blood transfusions for palliative care in hospice Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2021 · second_quarter · Q2
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Accumulator adjustor issues NCATS RFI on Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
Issues related to participation in the 340B Drug Discount Program
Funding for federal hemophilia programs
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · Q1
Funding for federal hemophilia programs
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Accumulator adjustor issues
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · Q1
Sickle Cell Disease Medicaid Demonstration Program draft legislation Making permanent Medicare telehealth expansions allowed during Public Health Emergency Coverage of blood transfusions for palliative care in hospice and home health benefit Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Healthcare issues related to hematologic diseases Submission of ICD-10-CM coding proposal on von Willebrand Disease and presentation at Panel Meeting
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · Q1
Breast cancer research at the Department of Defense
American Rescue Plan Act Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Policies related to COVID-19 vaccination distribution Comments to USPSTF on Breast Cancer Screening
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Rise Act (HR 869/S 289)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · Q1
Appropriations for access to telehealth services for children and youth with special health care needs
Policies related to telehealth Policies related to transition of care for children and youth with special health care needs
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
THE SOCIETY FOR MATERNAL-FETAL MEDICINE via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · Q1
Policies related to COVID-19 vaccinations and pregnant and lactating people Policies related to implementation of recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women
Appropriations for research related to use of therapeutics in pregnant and lactating people
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE, Vice President of the U.S.
THE SOCIETY FOR MATERNAL-FETAL MEDICINE via ARTEMIS POLICY GROUP LLC
2021 · first_quarter · RR
Advance maternal therapeutics and increase understanding of the safety and efficacy of prescription drugs, therapeutics, and vaccines used during pregnancy and breastfeeding
Advance maternal therapeutics and increase understanding of the safety and efficacy of prescription drugs, therapeutics, and vaccines used during pregnancy and breastfeeding
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2020 · fourth_quarter · Q4
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Coverage for telemedicine in Medicare Hemophilia SNF Access Act (S. 3233 / H.R. 5952) HR 133, Consolidated Omnibus Appropriations Act
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans
Issues related to participation in the 340B Drug Discount Program Congressional RFI regarding the 340B Program
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2020 · fourth_quarter · Q4
Comment Letter on FDA Draft Guidance on the Development of Drugs and Biologicals for AML
FY 2021 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding HR 133, Consolidated Omnibus Appropriations Act
Sickle Cell Disease Medicaid Demonstration Program draft legislation Comment Letter on Medicare Physician Fee Schedule Proposed Rule for CY 2021 Comment Letter of Most Favored Nation Drug Reimbursement Policy Interim Final Rule Making permanent Medicare telehealth expansions allowed during Public Health Emergency Coverage of blood transfusions for palliative care in hospice and home health benefit Letter to Congress on Medicare policies related to evaluation and management services and the conversion factor for CY 2021 Outreach to President-elect Bidens transition team on evaluation and management services policies HR 133, Consolidated Omnibus Appropriations Act National Coverage Determination on myelodysplastic syndromes (MDS)
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2020 · fourth_quarter · Q4
Health disparities Health Equity and Accountability Act (H.R. 63370 Improving Social Determinants of Health Act (H.R. 6561) Clinical trial continuation Policies to increase clinical trial diversity Executive Orders related to insurance coverage and drug pricing Comment letter on Draft Guidance for Industry on Developing Drugs for Treatment of Premenopausal Women With Breast Cancer: Policies related to use of biosimilars in cancer treatment Comprehensive Breast Reconstruction Act of 2020 (H.R. 8558) Policies related to telehealth Policies related to COVID-19 vaccination distribution
Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Coverage for telemedicine in Medicare Metastatic Breast Cancer Access to Care Act (HR 2178/S 1374) Multi Cancer Early Detection Screening Coverage Act (HR 8845) Proposed waivers under Sections 1115 and 1332 of the Social Security Act Proposed rule related to Securing Updated and Necessary Statutory Evaluations Timely Proposed rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency Proposed rules on Notice of Benefit and Payment Parameters Interim final rule on Most Favored Nation policy Radiation Oncology Alternative Payment Model
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2020 · fourth_quarter · Q4
Comment letter on Request for Information: A Blueprint for Change: Guiding Principles for Advancing the System of Services for Children and Youth with Special Health Care Needs (CYSHCN) and Families
Filing targets: Health Resources & Services Administration (HRSA)
CHILD NEUROLOGY FOUNDATION via ARTEMIS POLICY GROUP LLC
2020 · third_quarter · RR
Telehealth and transitions from pediatric to adult care.
Telehealth and transitions from pediatric to adult care.
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2020 · third_quarter · Q3
Comment Letter on FDA Draft Guidance on the Development of Drugs and Biologicals for AML Comment letter on Cures 2.0 proposal
Sickle Cell Disease Medicaid Demonstration Program draft legislation Comment Letter on Medicare Physician Fee Schedule Proposed Rule for CY 2021 Comment Letter on Medicare Inpatient Prospective Payment System Proposed Rule for FY 2021 Medicaid Value-Based Pricing Proposed Rule Making permanent Medicare telehealth expansions allowed during Public Health Emergency Coverage of blood transfusions for palliative care in hospice and home health benefit
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2020 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Coverage for telemedicine in Medicare Hemophilia SNF Access Act (S. 3233 / H.R. 5952)
Funding for federal hemophilia programs
Issues related to participation in the 340B Drug Discount Program
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2020 · third_quarter · Q3
Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Coverage for telemedicine in Medicare Metastatic Breast Cancer Access to Care Act (HR 2178/S 1374) FY21 Inpatient Prospective Payment System Proposed Rule 2021 Medicare Physician Fee Schedule Proposed Rule 2021 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Health disparities Clinical trial continuation Policies to increase clinical trial diversity Executive Orders related to insurance coverage and drug pricing FDA Office of Womens Health RFI Policies related to telehealth Research Investment to Spark the Economy Act (RISE Act) (HR 7308 / S 4286) Policies related to COVID-19 vaccination distribution
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · Q2
Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Coverage for telemedicine in Medicare Medicare interim final rule related to COVID emergency
FY21 Labor, HHS, Education Appropriations bills DOD Breast Cancer medical research program
Patient Protection and Affordable Care Enhancement Act, HR 1425 Families First Coronavirus Response Act, HR 6201 Coronavirus Aid, Relief, and Economic Security Act, HR 748 HEROES ACT, HR 6800 HELP Committee pandemic preparedness paper Paid medical leave Triage policies Health disparities Clinical trial continuation Clinical trial diversity
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · Q2
The Paycheck Protection Program and Health Care Enhancement Act, HR 266 Health Economic Recovery Omnibus Emergency Solutions Act (HEROES ACT), HR 6800 Paycheck Protection Program and Health Care Enhancement Act (COVID 3.5) Patient Protection and Affordable Care Enhancement Act, HR 1425 Families First Coronavirus Response Act, HR 6201 Coronavirus Aid, Relief, and Economic Security Act, HR 748 Health disparities
FY 2021 Labor HHS Appropriations bills
Interim Final Rules on COVID 19 Public Health Emergency Sickle Cell Disease Medicaid Demonstration Program draft legislation Coverage of blood transfusions for palliative care in hospice and home health benefit
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · Q2
Funding for federal hemophilia programs
Issues related to participation in the 340B Drug Discount Program
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans
SUSAN G. KOMEN via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · RR
Funding for breast cancer research program. HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy
Funding for breast cancer research program. HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy
AMERICAN SOCIETY OF HEMATOLOGY via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · RR
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations Research in hematology Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule Medicaid Sick Cell Disease Demonstration HR 1409, Cancer Drug Coverage Parity Act Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations Research in hematology Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule Medicaid Sick Cell Disease Demonstration HR 1409, Cancer Drug Coverage Parity Act Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2020 · second_quarter · RR
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies to support National Breast Cancer Awareness Month
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act Comments RE: Proposed Rule on Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program Policies related to inclusion of new ICD-10 codes for inflammatory breast cancer and the coverage of External Breast Prostheses in Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid H.R. 1, One Big Beautiful Bill Act
Access to clinical trials for underrepresented populations Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments Comments RE: Re: Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency
Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Medicare coverage policy for breast cancer treatments and services Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule outlining revisions to Medicare Advantage (MA) and Medicare Part D for Contract Year 2026. Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 842/S 339); a bill to provide for Medicare coverage of multi-cancer early detection screening tests.
Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, Comments in response to proposed updates to HRSA-Supported Womens Preventive Services Guidelines Policies to remove the notice and comment process for a wide array of agency actions Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Find It Early Act (H.R.3086/S.5141) Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator and maximizer adjustors Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) H.R. 1692 - Health Care Affordability Act of 2023; S. 8 - Improving Health Insurance Affordability Act of 2023 Letter to tri-agencies (Department of Health and Human Services, Treasury, Labor) re Enhancing Coverage of Preventive Services Under the Affordable Care Act Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) House Ways and Means Committee Request for Information - Tax Priorities Protect patients from substandard and junk insurance products
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R.3086/S.5141 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid PBM Reform amendments related to Medicaid and Medicare in Continuing Resolution draft legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Find It Early Act (H.R.3086/S.5141); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator and maximizer adjustors H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) H.R. 1692 - Health Care Affordability Act of 2023; a bill to revise the tax credit for health care premium assistance to expand the eligibility of low-income taxpayers for such credit and reduce the cost of health care premiums S. 8 - Improving Health Insurance Affordability Act of 2023; a bill to expand the eligibility of taxpayers for the refundable tax credit for coverage under a qualified health plan and increases cost-sharing subsidies under the Patient Protection and Affordable Care Act
Outreach to the Dr. Bertagnolli, NIH Director, and the Office of the Director
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, including comments on the proposed rule to regulate Medical Devices; Laboratory Developed Tests The Patent Eligibility Restoration Act (S.2140) Policies related to ICD-10 code for inflammatory breast cancer Comments in response to Congressional Next-Generation Cures package Comments in response to the House Energy & Commerce Committee Framework for Discussion on Reforming the National Institutes of HealthProhibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023) Comments in response to Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies (FDA-2021D-0789)
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY25 House and Senate Labor-HHS Appropriations bills (H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025) Policies related to report language on the implementation of the Medicare Prescription Payment Plan. Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, including comments on the proposed rule to regulate Medical Devices; Laboratory Developed Tests Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA) (S. 2243) The Patent Eligibility Restoration Act (S.2140) Policies related to ICD-10 code for inflammatory breast cancer
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills FY25 House and Senate Labor-HHS Appropriations bills Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act, including comments on proposed rule re: Federal Independent Dispute Resolution Operations Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator adjustors Letter to Committee on Education and the Workforce Request for Information on Employer-Sponsored Insurance and Employee Retirement Income Security Act (ERISA)
H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Outreach to the Dr. Bertagnolli, NIH Director, and the Office of the Director Outreach to the White House RE: Initiative on Women's Health Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Meeting with CMS HR 3561 Section related to Medicaid transparency and drug pricing Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of, White House Office
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act (H.R. 4189/S. 2016) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Comments on Processes for Assessing Compliance with Mental Health Parity and Addiction Equity in Medicaid and CHIP Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Equitable Community Access to Pharmacist Services Act (S. 2477/H.R. 1770) Access to Genetic Counselor Services Act (H.R.3876/S.2323) Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P). Comments RE OIG Solicitation New and Modified Safe Harbors and Special Fraud Alerts OIG-1123-N, 88 Fed. Reg. 84116 requesting permission for sponsors of clinical trials targeting cancer or other life-threatening diseases or conditions to cover certain indirect costs incurred by clinical trial participants. Comments RE: Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills FY25 House and Senate Labor-HHS Appropriations bills Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.
H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Outreach to the Dr. Bertagnolli, NIH Director, and the Office of the Director Outreach to the White House RE: Initiative on Women's Health Research
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, including comments on the proposed rule to regulate Medical Devices; Laboratory Developed Tests Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA) (S. 2243) The Patent Eligibility Restoration Act (S.2140) Policies related to ICD-10 code for inflammatory breast cancer
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office
Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill Polices related to PBMs and drug cost transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office
Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy
Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act Comments related to the Mental Health Parity and Addiction Equity Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
Appropriations for the CDC
Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act Comments related to the Mental Health Parity and Addiction Equity Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act (H.R. 4189/S. 2016) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Comments on Processes for Assessing Compliance with Mental Health Parity and Addiction Equity in Medicaid and CHIP Efforts to introduce the Community Health Worker Access Act to improve access to Community Health Worker services for Medicare and Medicaid enrollees Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills Letter RE: House Budget Committees Health Care Task Force Request for Information on containing health care costs
H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter regarding Request for Information on Modernizing the National Institutes of Health (NIH) Letter supporting the nomination of Dr. Bertagnolli to NIH Director
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, including comments on the proposed rule to regulate Medical Devices; Laboratory Developed Tests Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA) (S. 2243) Comments in response to the discussion draft of the Stop Drug Shortages Act Letter to Congressional leadership related to drug shortages Letter in response to request for information on Modernizing the Centers for Disease Control and Prevention
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, White House Office
Funding for federal hemophilia programs
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill Comments on 503b facilities and compounding Drug Shortages RFI
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Appropriations for the CDC
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Cancer Drug Parity Act (S. 2039) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Find It Early Act (H.R.3086); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation
H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act (H.R. 4189/S. 2016) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Comments in response to the Medicare CY24 Physician Fee Schedule Proposed Rule Comments in response to the Medicare CY24 Hospital Outpatient Prospective Payment System Comments in response to Medicare Program; Calendar Year (CY) 2024 Home Health (HH) Prospective Payment System Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin Items and Services; Hospice Informal Dispute Resolution and Special Focus Program Requirements, Certain Requirements for Durable Medical Equipment Prosthetics and Orthotics Supplies; and Provider and Supplier Enrollment Requirements (CMS-1780-P) Comments in response to Solicitation of Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025 Comments in response to CMS-2434-P; Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill Comments on 503b facilities and compounding Drug Shortages RFI
Funding for federal hemophilia programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients
Appropriations for the CDC
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Reducing Hereditary Cancer Act (HR 1526/S. 765) CONNECT for Health Act Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Implementation of Lymphedema Treatment Act Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses tissue from the lower abdomen to create a new breast
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to HCPCS coding policy regarding DIEP-flap procedures Comments in response to USPSTF revised recommendations for breast cancer screening Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Appropriations for the CDC
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Access to Breast Cancer Diagnosis (ABCD) Act Safe Step Act (S. 652) Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 HELP Copays Act (H.R.830) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments in response to proposed 2024 Notice of Benefit and Payment Parameters Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY24 House and Senate Labor-HHS Appropriations bills
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE, White House Office
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans, including alternative funding model Policies related to co-pay accumulators, including The HELP Copays Act (HR 830) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FDA policies related to research and approvals of treatments for hematological diseases
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum Graduate medical education Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE)
Issues related to mifepristone
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA), White House Office
Reproductive Health Services Interim Final Rule, RIN: 2900-AR57
Permanent and mandatory extension of Medicaid for benefits for 12-months post-partum Graduate medical education Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA), White House Office
The Accelerating Kids Access to Care Act (AKACA) (HR 3089/S 1544) Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE) Comments in response to the Medicaid Eligibility and Enrollment NPRM (CMS-2421-P) H.R.2144 - Access to Genetic Counselor Services Act of 2021
Policies related to development of the Advanced Research Projects Agency for Health
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) DIVERSE Trials Act (H.R. 5030/S. 2706) Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584); a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes CURES 2.0 Act (H.R. 6000) Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Policies related to reauthorization of user fees at the Food and Drug Administration (H.R. 7667/ S. 4348) H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 Advanced Research Project Agency-Health Act (H.R.5585) Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act (S.3799) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 H.R. 9565/S. 5295- Comprehensive Cancer Survivorship Act Policies related to the reauthorization of FDA User Fee Agreements Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 Policies related to the implementation of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Section 1557, Nondiscrimination in Health Programs and Activities (RIN Number 0945-AA17) Request for Information on establishing a National Directory of Healthcare Providers and Services
H.R. 2617 - Consolidated Appropriations Act of 2023; Breast cancer research at the Department of Defense H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023
Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services and the Equitable Community Access to Pharmacist Services Act (H.R.7213) Medicare coverage policy for drugs and drug pricing H.R. 9505 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Comments regarding the temporary increase in federal medical assistance percentage (FMAP) in response to the COVID-19 Public Health Emergency (PHE) (CMS-9912-N) Comments in response to the Medicaid Eligibility and Enrollment NPRM (CMS-2421-P) Comments in response to the RFI regarding National Directory of Healthcare Providers & Services (CMS-0058-NC) Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE)
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to development of the Advanced Research Projects Agency for Health H.R. 2617 - Consolidated Appropriations Act of 2023
Making Advances in Mammography and Medical Options for Veterans Act (S.2533/H.R.4794) H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait The Sickle Cell Disease Treatment Centers Act (HR 8855/S 4866) 2022 Sickle Cell Disease Awareness Month Resolution The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Implementation of No Surprises Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services and the Equitable Community Access to Pharmacist Services Act (H.R.7213) Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024 Medicare coverage policy for drugs and drug pricing H.R. 5376 - Inflation Reduction Act of 2022; a budget reconciliation bill which included provisions to continue subsidies on private insurance premiums, address out of pocket costs in Medicare Part D, and more Comments in response to CMS Proposed Rule on CY 2023 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System (CMS 1772-P) Comments in response to CMS Request for Information on Medicare Advantage (CMS-4203-NC) Comments in response to CY2023 Medicare Physician Fee Schedule (CMS-1770-P)
Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) DIVERSE Trials Act (H.R. 5030/S. 2706) Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584); a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes CURES 2.0 Act (H.R. 6000) Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Policies related to reauthorization of user fees at the Food and Drug Administration (H.R. 7667/ S. 4348) H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 Advanced Research Project Agency-Health Act (H.R.5585) Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act (S.3799) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067/ H.R. 5769) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (H.R. 7045/S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act (S. 942) HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies regarding White House Cancer Moonshot implementation Issues related to regulation of short-term limited duration plans H.R. 5376 - Inflation Reduction Act of 2022; a budget reconciliation bill which included provisions to continue subsidies on private insurance premiums, address out of pocket costs in Medicare Part D, and more Comments on future rulemaking for the 2024 Notice on Benefit and Payment Parameters
Making Advances in Mammography and Medical Options for Veterans Act (S.2533/H.R.4794) H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait The Sickle Cell Disease Treatment Centers Act (HR 8855/S 4866) 2021 Sickle Cell Disease Awareness Month Resolution The Sickle Cell Care Expansion Act (H.R. 7177/S.4425) Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Implementation of No Surprises Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Policies related to development of the Advanced Research Projects Agency for Health
The Accelerating Kids Access to Care Act (AKACA) (HR 3089/S 1544)
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Abortion and reproductive health care access Maternal Mental Health Into the Light for Maternal Mental Health and Substance Use Disorders Act (S. 3824/H.R. 7073) TRIUMPH for New Moms Act of 2021 (H.R. 4217/S. 2779) Unwinding of the COVID-19 Public Health Emergency Initiatives related to inclusion of pregnant and lactating individuals in clinical research RFI on NIH-Wide Strategic Plan for Research on the Health of Women (Notice Number: NOT-OD-22-186)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Appropriations for access to telehealth services for children and youth with special health care needs Appropriation for Telehealth Resource Centers program at HRSA Policies related to paid family and medical leave
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to paid family and medical leave Policies related to development of the Advanced Research Projects Agency for Health Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc Addition in any reconciliation package of policies related to health insurance coverage and affordability, including permanent extension of Advanced Premium Tax Credits provided by the American Rescue Plan, closing the Medicaid coverage gap, and a cap on out-of-pocket costs for Medicare Part D beneficiaries Appropriation for Consumer Assistance Programs (CAPs)
Breast cancer research at the Department of Defense H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023
Making Advances in Mammography and Medical Options for Veterans Act (S.2533/H.R.4794) H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021
Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) DIVERSE Trials Act (H.R. 5030/S. 2706) Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584); a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes CURES 2.0 Act (H.R. 6000) Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Policies related to reauthorization of user fees at the Food and Drug Administration (H.R. 7667/ S. 4348)H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 Advanced Research Project Agency-Health Act (H.R.5585) Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act (S.3799) Comments to the FDA on Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry (FDA-2021-D0789) Comments to the FTC on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (FTC-2022-0015)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
FDA policies related to research and approvals of treatments for hematological diseases FDA-2021-D-0789 - Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry Draft Guidance for Industry - Considerations for the Development of Chimeric Antigen Receptor T Cell Products (Docket No. FDA-2021-D-0404) Comments to the FTC on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (FTC-2022-0015)
FY 2023 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Funding for federal hemophilia programs
Issues related to participation in the 340B Drug Discount Program Comments to the FTC on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (FTC-2022-0015)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Appropriations for access to telehealth services for children and youth with special health care needs Build Back Better Act (HR 5376) Policies related to paid family and medical leave
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act(HR 4612/S.2412) Safe Step Act (H.R. 2163/S. 464) The Closing Health Coverage Gaps for Public Servants Act (S. 3796) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act HELP Copays Act (H.R.5801), accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies regarding White House Cancer Moonshot implementation Issues related to regulation of short-term limited duration plans
Making Advances in Mammography and Medical Options for Veterans Act (S.2533/H.R.4794) H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021
Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) DIVERSE Trials Act (H.R. 5030/S. 2706) Diverse and Equitable Participation in Clinical Trials (DEPICT) Act (H.R.6584); a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes CURES 2.0 Act (H.R. 6000) Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Comments regarding the nomination of Robert Califf as FDA Commissioner Legislation to reauthorize the National Breast and Cervical Cancer Early Detection Program Advanced Research Project Agency-Health Act (H.R.5585) Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act (S.3799) Response to Requests for Information from the Healthy Futures Task Force
Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 Waivers in Medicaid Comments related to the Notice of Benefit and Payment Parameters for 2023 Policies related to Medicare coverage for pharmacy services and the Equitable Community Access to Pharmacist Services Act (H.R.7213)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait 2021 Sickle Cell Disease Awareness Month Resolution Healthcare issues related to hematologic diseases CURES 2.0 draft legislation (H.R. 6000) Responding to Social Determinants of Health Caucus Request for Information Implementation of No Surprises Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Multi-Cancer Early Detection Screening Coverage Act (HR 1946/S 1873) Lymphedema Treatment Act (HR 3630/ S 1315) Breast Cancer Patient Equity Act (HR 3087/S 2051) Reducing Hereditary Cancer Act of 2021 (HR 4110) CONNECT for Health Act (S.1512/ H.R. 2903) Improving Seniors' Timely Access to Care Act (H.R.3173) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Seniors Prescription Drug Relief Act (S.2327) Medicare coverage policy for breast cancer treatments and services Radiation Oncology Alternative Payment Model Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Policies related to rescission of the Most Favored Nation (MFN) Model
Breast cancer research at the Department of Defense H.R. 4350/S. 1605 - National Defense Authorization Act for Fiscal Year 2022; a bill to authorize Department of Defense activities and programs for FY 2022
Making Advances in Mammography and Medical Options for Veterans Act (S.2533/H.R.4794) H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021
Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) DIVERSE Trials Act (H.R. 5030/S. 2706) CURES 2.0 Act (H.R. 6000) Policies related to cancer survivorship Policies related to development of the Advanced Research Projects Agency for Health Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people Request to become Health People 2030 Champion Outreach regarding National Breast Cancer Awareness (NBCAM) Month Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to the HHS Strategic Plan Policies related to repeal of the HHS Good Guidance Practices Rule Policies related to repeal of the HHS SUNSET Rule Comments regarding the nomination of Robert Califf as FDA Commissioner
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Issues related to participation in the 340B Drug Discount Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Access to Breast Cancer Diagnosis (ABCD) Act (S. 1067) Metastatic Breast Cancer Access to Care Act (S. 1312 / HR 3182) Cancer Drug Coverage Parity Act (HR 4385) Protecting Access to Lifesaving Screening (PALS) Act Safe Step Act (H.R. 2163/S. 464) Protecting Americans with Pre-Existing Conditions Act of 2021 (S. 779) Implementation of the Affordable Care Act Implementation of the No Surprises Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act Accumulator adjustor issues Cancer survivorship issues Issues related to prescription drug affordability for patients
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289) Build Back Better Act (HR 5376)
National Cancer Research Month (S Res 253) Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Expanding Access to Affordable Prescription Drugs and Medical Devices Act (S.2257) CURES 2.0 draft legislation Policies related to cancer survivorship Policies related to development of the Advanced Research Projects Agency for Health Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people Policies related to development of a public option Guidance related to use of patient reported outcomes in clinical trials Request to become Health People 2030 Champion Responding to Social Determinants of Health Caucus Request for Information OMB RFI on Methods and Leading Practices for Advancing Equity and Support for Underserved Communities through Government
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Sickle Cell Disease Medicaid Demonstration Program draft legislation Making permanent Medicare telehealth expansions allowed during Public Health Emergency The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Funding for federal hemophilia programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Breast cancer research at the Department of Defense
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations report language related to metastatic breast cancer Appropriations for breast cancer research Consumer Assistance Programs support Public Health Infrastructure Saves Lives Act (S 674) Rise Act (HR 869/S 289)
American Rescue Plan Act National Cancer Research Month (S Res 253) Health disparities Access to clinical trials for underrepresented populations Improving Social Determinants of Health Act (S.104/H.R.379) Comprehensive Breast Reconstruction Act of 2021 (H.R. 469) Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
FDA policies related to research and approvals of treatments for hematological diseases
FY 2022 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding Suggested Labor HHS Committee Report Language for CMS on improving value of evaluation and management codes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of the Hemophilia SNF Access Act HR 3, Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to participation in the 340B Drug Discount Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
FY 2022 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program and HRSA Sickle Cell Disease Regional Demonstration Program Funding for Hematology research and NIH total funding Suggested Labor HHS Committee Report Language for CMS on improving value of evaluation and management codes
FDA policies related to research and approvals of treatments for hematological diseases
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Medicare coverage policy for breast cancer treatments and services Medicare coverage policy for the six protected classes of drug treatments Policies related to work requirements in Medicaid Policies related to Medicaid block grants Policies related to funding for Medicaid expansion Radiation Oncology Alternative Payment Model Telehealth
Access to Breast Cancer Diagnosis (ABCD) Act Metastatic Breast Cancer Access to Care Act Cancer Drug Coverage Parity Act Implementation of the Affordable Care Act Policies related to insurance coverage and COVID-19 Junk Plan Accountability and Disclosure Act (S. 1002) No Junk Plans Act Accumulator adjustor issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Funding for federal hemophilia programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Healthcare issues related to hematologic diseases Call on ICD-10-CM coding proposal on von Willebrand Disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Access to Breast Cancer Diagnosis (ABCD) Act (S. 3216 / H.R. 2428) Implementation of the Affordable Care Act Surprise medical billing Cancer Drug Parity Act (S. 741 / H.R. 1730) S. 4557, The COVER Act Policies related to COVID and immunocompromised populations Policies related to co-pay assistance programs
HR 133, Consolidated Omnibus Appropriations Act
National Defense Authorization Act for Fiscal Year 2021 (H.R.6395)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
FY 2021 House and Senate Labor HHS Appropriations bills Funding for CDC Sickle Cell Disease Data Collection Program Amendment to House FY 2021 Appropriations Bill Funding for Hematology research and NIH total funding
Resolution in honor of September as sickle cell disease awareness month Health disparities as they relate to sickle cell disease Issues related to sickle cell disease and sickle cell trait Healthcare issues related to hematologic diseases
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
FY21 National Defense Authorization Act
Access to Breast Cancer Diagnosis (ABCD) Act (S. 3216 / H.R. 2428) Implementation of the Affordable Care Act Surprise medical billing Cancer Drug Parity Act (S. 741 / H.R. 1730) S. 4557, The COVER Act Proposed Rule related to Grandfathered Plans Proposed Rule related to IRS policies for Medicare Care Arrangements Policies related to COVID and immunocompromised populations Policies related to co-pay assistance programs
FY21 Labor, HHS, Education Appropriations bills DOD Breast Cancer medical research program
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
FY21 National Defense Authorization Act
Access to Breast Cancer Diagnosis (ABCD) Act (S. 3216 / H.R. 2428) Implementation of the Affordable Care Act Surprise medical billing H.R. 6514, the Worker Health Coverage Protection Act Insurance provisions of COVID packages Cancer Drug Parity Act (S. 741 / H.R. 1730)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Coverage for telemedicine in Medicare Hemophilia SNF Access Act (S. 3233 / H.R. 5952) Medicare interim final rule related to COVID emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Funding for breast cancer research program. HR 2428, ABCD Act S 1895, Lower Health Care Costs Act Implementation of Affordable Care Act S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019 Surprise Medical Billing Medicare Coverage policies for drugs; drug pricing; Medicaid coverage policy
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations Research in hematology Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule Medicaid Sick Cell Disease Demonstration HR 1409, Cancer Drug Coverage Parity Act Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations Research in hematology Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule Medicaid Sick Cell Disease Demonstration HR 1409, Cancer Drug Coverage Parity Act Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations Research in hematology Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule Medicaid Sick Cell Disease Demonstration HR 1409, Cancer Drug Coverage Parity Act Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act